BRAF fusions are associated with a favorable prognosis, in part related to B-raf’s role in promoting oncogene-induced senescence in tumors, as well as its frequent occurrence in pilocytic astrocytomas, which inherently have favorable outcomes (109, 111–113). This evidence concerns the gene BRAF and pilocytic astrocytoma.